(Q68540900)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2205078%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

title

Fibrinolytic activity after subarachnoid haemorrhage and the effect of tranexamic acid (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2205078%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

1 reference

S A Tsementzis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2205078%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

W P Honan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2205078%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

S Nightingale

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2205078%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

E R Hitchcock

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2205078%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

C H Meyer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2205078%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

publication date

1 January 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2205078%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2205078%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

volume

103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2205078%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

issue

3-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2205078%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

page(s)

116-121

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2205078%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01407517

25 September 2019

exact match

0 references

cites work

Antifibrinolytic treatment in subarachnoid haemorrhage: present state

1 reference

12 December 2020

Antifibrinolysis with tranexamic acid in aneurysmal subarachnoid hemorrhage: a consecutive controlled clinical trial

1 reference

12 December 2020

Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms. A double-blind placebo-controlled study

1 reference

12 December 2020

The use of antifibrinolytic drugs to prevent early recurrent aneurysmal subarachnoid haemorrhage

1 reference

12 December 2020

Epsilon-aminocaproic acid and recurrent subarachnoid hemorrhage: a clinical trial

1 reference

12 December 2020

Fibrinolysis in subarachnoid haemorrhage

1 reference

12 December 2020

Methods for Determination of Plasmin, Antiplasmin and Plasminogen by Means of Substrate S-2251

1 reference

12 December 2020

Streptokinase clot lysis time in patients with ruptured intracranial aneurysms

1 reference

12 December 2020

Intracranial Aneurysms and Subarachnoid Hemorrhage. A Cooperative Study. Antifibrinolytic Therapy in Recent Onset Subarachnoid Hemorrhage

1 reference

12 December 2020

Monitoring fibrinolytic activity in the cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: a guide to the risk of rebleeding?

1 reference

12 December 2020

Monitoring of antifibrinolytic therapy following subarachnoid hemorrhage. The importance of CSF fibrin/fibrinogen degradation products

1 reference

12 December 2020

A Rapid, Simple, Sensitive Method for Measuring Fibrinolytic Split Products in Human Serum

1 reference

12 December 2020

Source of fibrin/fibrinogen degradation products in the CSF after subarachnoid hemorrhage

1 reference

12 December 2020

Quantitative determination of plasma fibrinolytic activity in patients with ruptured intracranial aneurysms who are receiving epsilon-aminocaproic acid: relationship of possible complications of therapy to the degree of fibrinolytic inhibition

1 reference

12 December 2020

Antifibrinolytic Treatment in Subarachnoid Hemorrhage

1 reference

12 December 2020

Preoperative management of patients with ruptured intracranial aneurysms

1 reference

12 December 2020

Effect of tranexamic acid on rebleeding after subarachnoid hemorrhage: a double-blind controlled clinical trial

1 reference

12 December 2020

Preoperative treatment of ruptured intracranial aneurysms with tranexamic acid and monitoring of fibrinolytic activity

1 reference

12 December 2020

Antifibrinolytic therapy for intracranial aneurysms

1 reference

12 December 2020

Use of an anti-fibrinolytic agent (tranexamic acid) in the management of ruptured intracranial aneurysms

1 reference

12 December 2020

Plasminogen in Normal and Abnormal Human Cerebrospinal Fluid

1 reference

12 December 2020

Spontaneous subarachnoid hemorrhage complicated by communicating hydrocephalus: epsilon amino caproic acid as a possible predisposing factor

1 reference

12 December 2020

Hypothermia, and interruption of carotid, or carotid and vertebral circulation, in the surgical management of intracranial aneurysms.

1 reference

12 December 2020

Fibrinolytic Activity in Blood and Cerebrospinal Fluid in Subarachnoid Hemorrhage from Ruptured Intracranial Saccular Aneurysm before and during EACA Treatment

1 reference

12 December 2020

The fibrin plate method for estimating fibrinolytic activity

1 reference

12 December 2020

Tranexamic acid in subarachnoid hemorrhage. A double-blind study

1 reference

12 December 2020

Prevention of recurrence of spontaneous subarachnoid haemorrhage by tranexamic acid

1 reference

12 December 2020

Prolonged antifibrinolysis: an effective non-surgical treatment for ruptured intracranial aneurysms?

1 reference

12 December 2020

Use of epsilon aminocaproic acid (EACA) in the preoperative management of ruptured intracranial aneurysms

1 reference

12 December 2020

Monitoring antifibrinolytic therapy in subarachnoid hemorrhage

1 reference

12 December 2020

A new method for the determination of fibrinogen in small samples of plasma.

1 reference

12 December 2020

Tranexamic acid in the preoperative management of ruptured intracranial aneurysms

1 reference

12 December 2020

Treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm with tranexamic acid: A double-blind clinical trial

1 reference

12 December 2020

Coagulation and fibrinolysis in blood and cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: effect of tranexamic acid (AMCA)

1 reference

12 December 2020

Fibrinolytic activity of the cerebrospinal fluid after subarachnoid haemorrhage.

1 reference

12 December 2020

Fibrinolytic activity of cerebral tissue after experimental subarachnoid haemorrhage: inhibitory effect of tranexamic acid (AMCA)

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01407517

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2205078%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

1 reference